Cancer clinical trials in the region Île-de-France

374 currently recruiting clinical trials

If you are a doctor and would like find matching clinical trials for you patients, create an account or log in

If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial

Early Access Lymphoma

Accès précoce post-AMM – COLUMVI (Glofitamab)

B cell lymphoma Large B cell lymphoma 2 3 or more

Systemic Treatment-Naive

Hoffmann-La Roche

Early Access Lung cancer

Accès précoce pré-AMM– IMFINZI (Durvalumab)

SCLC (Small Cell Lung Cancer) Localized Locally Advanced None Chemotherapy Radiotherapy Chemotherapy Radiotherapy

AstraZeneca

Early Access Lung cancer

Accès précoce pré-AMM– RYBREVANT (Amivantamab)

NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR None Systemic Treatment-Naive

Janssen

Early Access Lung cancer

Accès précoce pré-AMM– RYBREVANT (Amivantamab)

NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR 1 Targeted therapy

Systemic Treatment-Naive

Janssen

Early Access Lymphoma

Accès précoce post-AMM – COLUMVI (Glofitamab)

B cell lymphoma Large B cell lymphoma 1

Systemic Treatment-Naive

Hoffmann-La Roche

Phase 3 Stomach and esophageal cancer #NCT06901531 #2024-519773-19-00

[LUCERNA] Étude du ZOLBETUXIMAB associé au PEMBROLIZUMAB et à la chimiothérapie chez les adultes atteints d'un cancer gastrique

Stomach Oesogastric junction Adenocarcinoma Locally Advanced Metastatic Claudin 18.2 PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) None Systemic Treatment-Naive

HER2 Immunotherapy Chemotherapy

Hôpital Saint Antoine AP-HP (Paris), Hôpital Saint Antoine AP-HP (Paris), Hôpital Saint Louis AP-HP (Paris), Hôpital Européen Georges Pompidou - AP-HP (Paris), Hôpital Européen Georges Pompidou - AP-HP (Paris)

Astellas Pharma Développement mondial, Inc.

Phase 3 Lung cancer #NCT06430866

NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Localized Locally Advanced None Surgery Chemotherapy Surgery Chemotherapy

ALK EGFR ROS-1 Immunotherapy Immunotherapy

Hôpital Bichat - Claude Bernard - AP-HP (Paris)

Amgen

Phase 3 Breast cancer #NCT05514054 #2022-501007-28-00

[EMBER-4] Étude de l'IMMUNESTRANT vs l'hormonothérapie standard chez des patientes atteintes d'un cancer du sein précoce

HER2 Negative HR Positive Localized None Hormone therapy

Hôpital Henri-Mondor AP-HP (Créteil), Groupe Hospitalier Diaconesses - Site Croix Saint Simon (Paris), Hôpital Tenon AP-HP (Paris ), Institut Curie - Paris (Paris), Hôpital Saint Louis AP-HP (Paris) (and 3 more...)

Eli Lilly et compagnie

Phase 3 Breast cancer #NCT07060807

[HERTHENA-Breast04] Étude clinique du PATRITUMAB DERUXTECAN pour le traitement du cancer du sein

HER2 Negative HR Positive Locally Advanced Metastatic None 1 Targeted therapy Hormone therapy

BRCA 1/2 Chemotherapy

Gustave Roussy (Villejuif)

Merck Sharp & Dohme LLC

Phase 3 Lung cancer #NCT06472245 #2023-509340-10-00

Essai du vaccin thérapeutique contre le cancer, OSE2101, chez des patients atteints d'un cancer du poumon non à petites cellules et d'une résistance secondaire à un inhibiteur de point de contrôle immunitaire

NSCLC (Non-Small Cell Lung Cancer) Metastatic 1 2 3 or more Immunotherapy

ALK EGFR ROS-1 Systemic Treatment-Naive

Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Gustave Roussy (Villejuif), Hôpital Tenon AP-HP (Paris ), Hôpital Saint-Joseph (Paris), Hôpital Avicenne - AP-HP (Bobigny)

OSE Immunotherapeutics